(Q35158955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Stanley R Riddell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Carolina Berger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Makoto Murata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sophia Randolph

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

153-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818225%20AND%20SRC:MED&resulttype=core&format=json

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Natural killer cells, viruses and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Biology of natural killer cells in cancer and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Skin graft rejection by beta 2-microglobulin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Murine natural killer cells and marrow graft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Genomic approaches to the pathogenesis of hematologic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

CD8+ T Cell Effector Mechanisms in Resistance to Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Cellular and cytokine effectors of acute graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Immunodominance and tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Functional coherence of the human Y chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Identification of a graft versus host disease-associated human minor histocompatibility antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900007-9

7 January 2021